Why the study?
Long QT syndrome type 1 is associated with high risk for Torsade de Pointes arrhythmias and sudden cardiac death, making drugs targeting IKs of high interest as antiarrhythmics.
Does the IKs activator ML277 reduce dofetilide-induced Torsade de Pointes arrhythmias in a chronic atrioventricular block dog model?
Does the IKs activator ML277 reduce dofetilide-induced Torsade de Pointes arrhythmias in a chronic atrioventricular block dog model?
IKs channel activation by ML277 temporarily suppressed QT interval prolongation and reduced arrhythmic outcomes in a CAVB dog model, highlighting its potential as an antiarrhythmic approach.
Answers are grounded in this paper and cite their sources.
ML277 effects in CAVB dogs are hypothesis-generating; leaves open clinical translation for LQT1 TdP prevention.
Long QT syndrome type 1 with affected IKs is associated with a high risk for developing Torsade de Pointes (TdP) arrhythmias and eventually sudden cardiac death. Therefore, it is of high interest to explore drugs that target IKs as antiarrhythmics. We examined the antiarrhythmic effect of IKs channel activator ML277 in the chronic atrioventricular block (CAVB) dog model. TdP arrhythmia sensitivity was tested in anesthetized mongrel dogs (n = 7) with CAVB in series: (1) induction experiment at 4 ± 2 weeks CAVB: TdP arrhythmias were induced with our standardized protocol using dofetilide (0.025 mg/kg), and (2) prevention experiment at 10 ± 2 weeks CAVB: the antiarrhythmic effect of ML277 (0.6–1.0 mg/kg) was tested by infusion for 5 min preceding dofetilide. ML277: (1) temporarily prevented repolarization prolongation induced by dofetilide (QTc: 538 ± 65 ms at induction vs. 393 ± 18 ms at prevention, p < 0.05), (2) delayed the occurrence of the first arrhythmic event upon dofetilide (from 129 ± 28 s to 180 ± 51 s, p < 0.05), and (3) decreased the arrhythmic outcome with a significant reduction in the number of TdP arrhythmias, TdP score, arrhythmia score and total arrhythmic events (from 669 ± 132 to 401 ± 228, p < 0.05). IKs channel activation by ML277 temporarily suppressed QT interval prolongation, delayed the occurrence of the first arrhythmic event and reduced the arrhythmic outcome in the CAVB dog model.
No takes yet. Share an insight, caveat, or question.
Bavel et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: